Últimas noticias sobre BanColombia (NYSE:CIB) Bolsa

BanColombia

BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala.

BanColombia SA

COMML INTL BK S/ADR by Commercial International Bank Ltd.

Commercial International Bank - Egypt CIB

CIB MARINE BANCSHARES by CIB Marine Bancshares, Inc.

CIB Marine Bancshares Inc

COMMUTY INV BANCORP INC by Community Investors Bancorp, Inc.

Community Investors Bancorp Inc

First Trust NASDAQ Cybersecurity ETF

CIBL Inc

BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) is set to give its latest quarterly earnings report on Thursday, 2024-11-07. Here's what investors need to know before the announcement.
Analysts estimate that BanColombia will report an earnings per share (EPS) of $1.42. 
The market awaits BanColombia's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.08, leading to a 0.0% drop in the share price the following trading session.
Here's a look at BanColombia's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.52</td>
<td>1.50</td>
<td>1.37</td>
<td>1.42</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.44</td>
<td>1.54</td>
<td>1.58</td>
<td>1.53</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>0.0%</td>
<td>3.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730912622_0.png" alt="eps graph" />
<h3>Tracking BanColombia's Stock Performance</h3>
Shares of BanColombia were trading at $32.22 as of November 05. Over the last 52-week period, shares are up 20.33%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CIB/earnings">To track all earnings releases for BanColombia visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Earnings Preview: BanColombia

Across the recent three months, 4 analysts have shared their insights on BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $34.25, a high estimate of $36.00, and a low estimate of $32.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 4.2%. 
<img src="https://www.benzinga.com/files/images/story/2024/1724954471_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive BanColombia. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ernesto Gabilondo</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$34.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Tito Labarta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$32.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Yuri Fernandes</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Yuri Fernandes</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$36.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to BanColombia. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of BanColombia compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of BanColombia's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into BanColombia's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CIB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on BanColombia analyst ratings.</a>
<h2>Delving into BanColombia's Background</h2>
BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala.
<h3>Understanding the Numbers: BanColombia's Finances</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, BanColombia faced challenges, resulting in a decline of approximately -1.59% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 11.01%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): BanColombia's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.04%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): BanColombia's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.22%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: BanColombia's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.79.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Deep Dive Into BanColombia Stock: Analyst Perspectives (4 Ratings)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59e66622efacff0001251da7/martijn-rats">Morgan Stanley analyst Martijn Rats </a>downgraded the rating for Equinor ASA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) from Equal-Weight to Underweight and lowered the price target from $30.5 to $25.8. Equinor shares closed at $27.10 on Wednesday. <a href="https://www.benzinga.com/quote/eqnr/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities analyst Ernesto Gabilondo downgraded the rating for Bancolombia S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) from Neutral to Underperform and lowered the price target from $38 to $34. BanColombia shares fell 0.3% to close at $33.12 on Wednesday. <a href="https://www.benzinga.com/quote/cib/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/61decf5dab16510001921543/brian-harbour">Morgan Stanley analyst Brian Harbour</a> downgraded CAVA Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) from Overweight to Equal-Weight, but raised the price target from $90 to $110. Cava Group shares rose 0.3% to close at $118.44 on Wednesday. <a href="https://www.benzinga.com/quote/cava/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities analyst Madeline Brooks downgraded the rating for Okta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) from Buy to Underperform, while cutting the price target from $135 to $75. Okta shares fell 0.5% to settle at $96.54 on Wednesday. <a href="https://www.benzinga.com/quote/okta/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58bff746b85e930001906485/jason-kreyer">Craig-Hallum analyst Jason Kreyer </a>downgraded comScore, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCOR#NASDAQ">SCOR</a>) from Buy to Hold and lowered the price target from $18 to $8. comScore shares fell 4.3% to close at $6.71 on Wednesday. <a href="https://www.benzinga.com/quote/scor/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying OKTA stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="497" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29085546/image-298-1024x497.png" alt="" class="wp-image-520719" style="width:573px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29085546/image-298-1024x497.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29085546/image-298-300x146.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29085546/image-298-768x373.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29085546/image-298.png 1362w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>

News

Downgrades

Pre-Market Outlook

Trading Ideas

CAVA

EQNR

OKTA

SCOR

This Okta Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

B of A Securities analyst Ernesto Gabilondo downgrades BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) from Neutral to Underperform and lowers the price target from $38 to $34.

Price Target

B of A Securities Downgrades BanColombia to Underperform, Lowers Price Target to $34

Goldman Sachs analysts upgraded Banco Santander-Chile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSAC#NYSE">BSAC</a>) from Sell to Neutral, citing Chile as <a href="https://www.benzinga.com/news/large-cap/24/08/40441573/bhp-averts-strike-at-worlds-largest-copper-mine-stabilizes-chinese-copper-supply">an ideal place to do business</a> for Andean banks.
Goldman Sachs&#8217; Tito Labarta expects &#8220;strong earnings momentum at the bank in the medium term&#8221; and expects its EPS to grow 24% on average for the period from 2023 to the end of 2026 after profits fell sharply in 2023.
&#8220;The macro scenario in Chile also screens favorably when compared to the other Andean banks in our coverage, with better industry loan growth and significantly lower delinquency ratios,&#8221; Labarta said in a note.
Goldman Sachs maintains a price target of $21 on Banco Santander-Chile and expects the bank&#8217;s return on equity to rebound to 17.2% in 2024 and 18.5% in 2025 from 11.7% in 2023.&nbsp;
Read Also: <a href="http://BHP Faces Prolonged Strike Threat At The Largest Global Copper Mine">BHP Faces Prolonged Strike Threat At The Largest Global Copper Mine</a>
Meanwhile, Goldman Sachs downgraded Bancolombia S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) from Neutral to Sell. The firm expects &#8220;the weak earnings momentum to continue in the medium term&#8221; due to easing cycle pressures on net interest margin due to Colombia&#8217;s economy.
&#8220;Loan growth in Colombia is muted, negatively pressured by a still high level of interest rates and resilient inflation,&#8221; Labarta said.&nbsp;
&#8220;Moreover, the still high inflation and interest rate environment could hinder loan growth in the medium term and indicate that the credit cycle has not yet peaked.&#8221;
He also forecasted that the bank&#8217;s profitability should keep falling through 2025 and 2026 to 14.3% and 13.5%, respectively, staying in-line with Bancolombia's cost of equity of 13.8% but well below its pre-pandemic average of 19.2%. 
Price Action: Banco Santander-Chile gained 1.17% to $20.75 as of Tuesday&#8217;s mid-afternoon trading, while Bancolombia fell 4.57% to $33.20.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/news/events/24/08/40312619/wealth-minerals-taps-chilean-lithium-projects-to-meet-rising-global-demand">Wealth Minerals Taps Chilean Lithium Projects To Meet Rising Global Demand</a></li>
</ul>
Image courtesy of Banco Santander-Chile

Analyst Color

BSAC

Goldman Sachs Analysts Upgrade Santander-Chile, Expect Return On Equity To Rebound Over 17% In 2024 And 18.5% In 2025

Goldman Sachs analyst Tito Labarta downgrades BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) from Neutral to Sell and lowers the price target from $34 to $32.

Goldman Sachs Downgrades BanColombia to Sell, Lowers Price Target to $32

JP Morgan analyst Yuri Fernandes maintains BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) with a Underweight and lowers the price target from $36 to $35.

JP Morgan Maintains Underweight on BanColombia, Lowers Price Target to $35

BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) reported quarterly earnings of $1.44 per share which missed the analyst consensus estimate of $1.45 by 0.69 percent. The company reported quarterly sales of $1.323 billion which missed the analyst consensus estimate of $1.729 billion by 23.49 percent. This is a 15.24 percent increase over sales of $1.148 billion the same period last year.

Earnings Misses

BanColombia Q2 2024 GAAP EPS $1.44 Misses $1.45 Estimate, Sales $1.323B Miss $1.729B Estimate

JP Morgan analyst Yuri Fernandes maintains BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) with a Underweight and raises the price target from $35 to $36.

JP Morgan Maintains Underweight on BanColombia, Raises Price Target to $36

Deutsche Bank AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) benefits from a strong balance sheet position and revenue growth. Its strong liquidity profile aids sustainable capital distribution activities. However, a rise in expenses and a deterioration in credit quality are concerning.
Deutsche Bank continues to benefit from its deposit balance. The metric has witnessed a 2% CAGR over the last five years (ending in 2023) and the trend continued in the first quarter of 2024. Furthermore, the bank benefits from a diverse deposit base that spans multiple client categories and geographic regions. Also, as of Mar 31, 2024, the company&#39;s loan-to-deposit ratio was 75.7%, indicating a robust and steady capital foundation. We believe that a stable deposit level will benefit its balance sheet.
DB remains focused on strengthening its capital position. As of Mar 31, 2024, the Common Equity Tier 1 (CET 1) ratio was 13.4%. Risk-weighted asset (RWA) reductions and strong organic capital generation enabled the bank to see improvement in the CET1 ratio. As of Mar 31, 2024, &euro;15 billion of RWA reductions have been achieved, out of the target to reach &euro;25-30 billion in reductions by 2025-end. It expects to maintain a CET 1 ratio of approximately 13% by 2025.
Net revenues recorded a CAGR of 2.7% over the last five years (ended 2023), with this upswing persisting in the first quarter of 2024. Management is shifting focus from investment banking to more stable and capital-light businesses, like private bank, corporate bank and asset management units.
Shares of this Zacks Rank #3 (Hold) company have gained 20% on the NYSE over the past three months compared with the industry&#39;s growth of 10.8%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/4e/68122.jpg?v=1559669298" />
Image Source: Zacks Investment Research
The bank has seen a deterioration in its credit quality. Its provision for credit losses witnessed a CAGR of 23.4% over the last five years (ended 2023), with the rising trend continuing in the first quarter of 2024. The current volatile economic backdrop is expected to affect credit quality in the near term. We project provisions to be &euro;1.67 billion and &euro;3.91 billion in 2024 and 2025, respectively.
Due to the nature of its business, Deutsche Bank is involved in litigation, arbitration and regulatory processes in Germany as well as a number of other jurisdictions. The bank has already incurred considerable legal settlement fees, which have had a negative impact on its finances.
<h3>Bank Stocks Worth Considering</h3>
Some better-ranked foreign bank stocks are Banco Macro S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bma#NYSE">BMA</a>) and Bancolombia S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cib#NYSE">CIB</a>).
The consensus estimate for Banco Macro&#39;s current-year earnings has been revised 29.6% upward over the past 30 days. Over the past three months, shares of BMA have surged 69.9%. The stock currently sports a Zacks Rank #1 (Strong Buy).
Bancolombia S.A.&#39;s current-year earnings have been revised almost 1% upward over the past 30 days. Shares of CIB have gained 11.6% over the past three months. The stock currently carries a Zacks Rank #2 (Buy).
<a href="https://www.zacks.com/stock/news/2283456/deutsche-bank-s-db-deposit-base-aids-low-credit-quality-ails?cid=CS-BENZ-FT-analyst_blog|zer_report_update-2283456">To read this article on Zacks.com click here.</a>

Markets

Deutsche Bank's Deposit Base Aids, Low Credit Quality Ails

Ita&uacute; Unibanco Holding S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/itub#NYSE">ITUB</a>) has announced a corporate internal restructuring plan. This will include the merger of its wholly-owned subsidiary, Hipercard Banco M&uacute;ltiplo S.A. (&quot;Hipercard&quot;), subject to approval from the Central Bank of Brazil. The cost associated with executing and implementing the transaction is estimated to be approximately R$180,000 ($34,843). 
As part of the effort, all activities currently managed by Hipercard, including the administration of bank cards, will be transferred to Ita&uacute; Unibanco. The primary purpose of this merger is to achieve greater synergy among the companies and activities of the ITUB conglomerate. This will help streamline costs and enhance efficiency. 
Following the completion of the transaction, Hipercard will be dissolved as an entity and its assets will be taken over by ITUB. This will lead to a reduction in maintenance costs, rationalization in administrative and commercial activities and an improvement in the overall corporate structure. 
Ita&uacute; Unibanco will take over Hipercard&#39;s equity worth R$2.68 billion ($518 million). The merger will not result in any increase in capital or the issuance of new shares of ITUB. There will be no exchange ratio. Also, rules relating to withdrawal rights for dissenting shareholders will not apply. Overall, the transaction will not have any financial impact on Ita&uacute; Unibanco. 
This strategic move highlights ITUB&#39;s ability to adapt to the trends of the rapidly evolving market and strengthen its competitive placement. Through such efforts, the company is well-poised to improve its market leadership and drive sustainable growth in the long run.
Over the past six months, the company&#39;s shares on the NYSE have lost 3.1% against the industry&#39;s growth of 14.4%. 
&nbsp;&nbsp;<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/9d/67596.jpg?v=56193037" /> 
Image Source -&nbsp;Zacks Investment Research
At present, ITUB carries a Zacks Rank #3 (Hold).
<h3>Stocks to Consider</h3>
Some better-ranked foreign finance stocks are Bancolombia S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cib#NYSE">CIB</a>) and Banco Macro S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bma#NYSE">BMA</a>). 
Bancolombia S.A.&#39;s current-year earnings have been revised upward marginally over the past 30 days. Shares of CIB have gained 26.4% over the past six months. The stock currently sports a Zacks Rank #1 (Strong Buy). 
The consensus estimate for Banco Macro&#39;s current-year earnings have been revised 29.6% upward over the past 30 days. Over the past three months, shares of BMA have gained 46.5%. The stock currently flaunts a Zacks Rank #1.
<a href="https://www.zacks.com/stock/news/2280215/itau-unibanco-itub-announces-merger-proposal-with-hipercard?cid=CS-BENZ-FT-analyst_blog|company_news_-_finance_sector-2280215">To read this article on Zacks.com click here.</a>

ITUB

Itau Unibanco Announces Merger Proposal With Hipercard

B of A Securities analyst Ernesto Gabilondo reinstates BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) with a Neutral and announces $38 price target.

Initiation

B of A Securities Reinstates Neutral on BanColombia, Announces $38 Price Target

JP Morgan analyst Yuri Fernandes maintains BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) with a Underweight and raises the price target from $30 to $35.

JP Morgan Maintains Underweight on BanColombia, Raises Price Target to $35

Investors eagerly anticipate the dividend payout from Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) on January 01, 2024. With a payout of $0.71 per share and an annualized dividend yield of 6.61%, this reward is exclusively for shareholders who held the stock before the ex-dividend date on December 14, 2023
<h3>Comerica Recent Dividend Payouts</h3>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style><table>
<thead>
<tr>
<th>Ex-Date</th>
<th style="text-align: right;">Payments per year</th>
<th>Dividend</th>
<th>Yield</th>
<th>Announced</th>
<th>Record</th>
<th>Payable</th>
</tr>
</thead>
<tbody>
<tr>
<td>2023-12-14</td>
<td style="text-align: right;">4</td>
<td>$0.71</td>
<td>6.61%</td>
<td>2023-11-07</td>
<td>2023-12-15</td>
<td>2024-01-01</td>
</tr>
<tr>
<td>2023-09-14</td>
<td style="text-align: right;">4</td>
<td>$0.71</td>
<td>5.48%</td>
<td>2023-07-25</td>
<td>2023-09-15</td>
<td>2023-10-01</td>
</tr>
<tr>
<td>2023-06-14</td>
<td style="text-align: right;">4</td>
<td>$0.71</td>
<td>6.66%</td>
<td>2023-04-25</td>
<td>2023-06-15</td>
<td>2023-07-01</td>
</tr>
<tr>
<td>2023-03-14</td>
<td style="text-align: right;">4</td>
<td>$0.71</td>
<td>4.05%</td>
<td>2023-02-28</td>
<td>2023-03-15</td>
<td>2023-04-01</td>
</tr>
<tr>
<td>2022-12-14</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>3.87%</td>
<td>2022-11-08</td>
<td>2022-12-15</td>
<td>2023-01-01</td>
</tr>
<tr>
<td>2022-09-14</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>3.44%</td>
<td>2022-07-26</td>
<td>2022-09-15</td>
<td>2022-10-01</td>
</tr>
<tr>
<td>2022-06-14</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>3.25%</td>
<td>2022-04-26</td>
<td>2022-06-15</td>
<td>2022-07-01</td>
</tr>
<tr>
<td>2022-03-14</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>2.84%</td>
<td>2022-02-23</td>
<td>2022-03-15</td>
<td>2022-04-01</td>
</tr>
<tr>
<td>2021-12-14</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>3.12%</td>
<td>2021-11-02</td>
<td>2021-12-15</td>
<td>2022-01-01</td>
</tr>
<tr>
<td>2021-09-14</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>4.01%</td>
<td>2021-07-27</td>
<td>2021-09-15</td>
<td>2021-10-01</td>
</tr>
<tr>
<td>2021-06-14</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>3.83%</td>
<td>2021-04-27</td>
<td>2021-06-15</td>
<td>2021-07-01</td>
</tr>
<tr>
<td>2021-03-12</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>3.99%</td>
<td>2021-02-23</td>
<td>2021-03-15</td>
<td>2021-04-01</td>
</tr>
</tbody>
</table>
When comparing Comerica's dividend yield against its industry peers, the company sits comfortably in the middle, with its peer BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) having the highest annualized dividend yield at 9.31%.
<h3>Analyzing Comerica Financial Health</h3>
Companies that pay out steady cash dividends are attractive to income-seeking investors, and companies that are financially healthy tend to maintain their dividend payout schedule. For this reason, investors can find it insightful to see if a company has been increasing or decreasing their dividend payout schedule and if their earnings are growing. 
<h3>YoY Growth in Dividend Per Share</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1704121531_0.png" alt="dividend chart graph" />
The company demonstrated a positive dividend growth pattern from 2020 to 2023, with the dividend per share rising from $2.72 to $2.84. This signifies the company's commitment to consistently increasing shareholder dividends.
<h3>YoY Earnings Growth For Comerica</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1704121531_1.png" alt="earning chart graph" />
The earnings chart illustrates an increase in Comerica's earnings per share, from $3.63 in 2020 to $8.82 in 2023. This positive earnings growth provides income-seeking investors with optimism, as it suggests potential for higher cash dividend payouts in the future.
<h3>Recap</h3>
In this article, we explore the recent dividend payout of Comerica and its significance for shareholders. The company has decided to distribute a dividend of $0.71 per share today, which equates to an annualized dividend yield of 6.61%.
When comparing Comerica's dividend yield against its industry peers, the company sits comfortably in the middle, with its peer BanColombia having the highest annualized dividend yield at 9.31%.
Given that Comerica has experienced an increase in dividend per share from 2020 to 2023 along with an increase in earnings per share, it could signal that the company is in good financial standing and that they could be positioned to continue distributing their profits back to their investors.
It is advisable for investors to monitor the company's performance in the coming quarters to stay in the loop about any adjustments in financials or dividend disbursements.
\To read more news on Comerica <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Dividends

Comerica Coping with Challenges: Bouncing Back with Steady Distribution and Decreasing Investor Rewards

Tuesday marks the last chance for investors to receive the next dividend payout from BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of 88.35 cents per share. On Wednesday, BanColombia will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 88.35 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Wednesday. Shareholders who own CIB as of the end of Tuesday's session are eligible to receive the 88.35 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 12, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on BanColombia's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Tuesday Is Your Last Chance To Buy BanColombia Before The Dividend Payout

Upgrades

Intraday Update

ALHC

ALSN

BNTX

BSBR

CART

CHKP

ENPH

Embraer-Empresa Brasileira De Aeronautica

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

KVYO

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

NICE

PCTI

PLNT

PRTH

PTEN

SBRA

Hostess Brands, Inc. - Class A Common Stock

TWNK

VLTO

VRNS

VSTS

ZYXI

Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023

BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) has observed the following analyst ratings within the last quarter: 
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
These 5 analysts have an average price target of $31.52 versus the current price of BanColombia at $25.25, implying upside.
Below is a summary of how these 5 analysts rated BanColombia over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
<img src="https://www.benzinga.com/files/images/story/2023/1697464858_0.png" alt="price target chart" />
This current average represents a 14.81% decrease from the previous average price target of $37.00. 
<a href="https://www.benzinga.com/quote/CIB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on BanColombia analyst ratings.</a>
<h1>How Are Analyst Ratings Determined?</h1>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations for BanColombia's Future

Jefferies analyst Inigo Vega initiates coverage on BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) with a Hold rating and announces Price Target of $28.6.

Jefferies Initiates Coverage On BanColombia with Hold Rating, Announces Price Target of $28.6

BanColombia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) has observed the following analyst ratings within the last quarter: 
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
These 4 analysts have an average price target of $32.25 versus the current price of BanColombia at $27.115, implying upside.
Below is a summary of how these 4 analysts rated BanColombia over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
<img src="https://www.benzinga.com/files/images/story/2023/1695308443_0.png" alt="price target chart" />
This current average has decreased by 12.84% from the previous average price target of $37.00. 
<a href="https://www.benzinga.com/quote/CIB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on BanColombia analyst ratings.</a>
<h1>How Are Analyst Ratings Determined?</h1>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where BanColombia Stands With Analysts

<h3>Upgrades</h3>
According to Truist Securities, the prior rating for International Paper Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>) was changed from Hold to Buy. In the second quarter, International Paper showed an EPS of $0.59, compared to $1.24 from the year-ago quarter. The current stock performance of International Paper shows a 52-week-high of $41.89 and a 52-week-low of $29.00. Moreover, at the end of the last trading period, the closing price was at $33.72. 
According to B of A Securities, the prior rating for Nutanix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) was changed from Neutral to Buy. Nutanix earned $0.24 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $36.71 and a 52-week-low of $19.97. At the end of the last trading period, Nutanix closed at $33.75. 
For Enphase Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), Seaport Global upgraded the previous rating of Neutral to Buy. For the second quarter, Enphase Energy had an EPS of $1.47, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $339.88 and a 52-week-low of $116.86. At the end of the last trading period, Enphase Energy closed at $123.97. 
For European Wax Center Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>), Piper Sandler upgraded the previous rating of Neutral to Overweight. European Wax Center earned $0.11 in the second quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $20.70 and a 52-week-low of $12.02. At the end of the last trading period, European Wax Center closed at $17.24. 
Baird upgraded the previous rating for HealthEquity Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) from Neutral to Outperform. HealthEquity earned $0.53 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of $79.16 and a 52-week-low of $48.86. HealthEquity closed at $70.97 at the end of the last trading period. 
According to JP Morgan, the prior rating for New Jersey Resources Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NJR#NYSE">NJR</a>) was changed from Underweight to Neutral. New Jersey Resources earned $0.10 in the third quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $55.84 and a 52-week-low of $38.23. At the end of the last trading period, New Jersey Resources closed at $42.17. 
For Five9 Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>), Deutsche Bank upgraded the previous rating of Hold to Buy. For the second quarter, Five9 had an EPS of $0.52, compared to year-ago quarter EPS of $0.34. The current stock performance of Five9 shows a 52-week-high of $89.58 and a 52-week-low of $46.63. Moreover, at the end of the last trading period, the closing price was at $66.42. 
According to Morgan Stanley, the prior rating for Buenaventura Mining Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BVN#NYSE">BVN</a>) was changed from Equal-Weight to Overweight. Buenaventura Mining Co earned $0.03 in the second quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Buenaventura Mining Co shows a 52-week-high of $8.92 and a 52-week-low of $5.75. Moreover, at the end of the last trading period, the closing price was at $8.26. 
According to Keefe, Bruyette &amp; Woods, the prior rating for Truist Financial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) was changed from Market Perform to Outperform. Truist Finl earned $0.95 in the second quarter, compared to $1.20 in the year-ago quarter. The current stock performance of Truist Finl shows a 52-week-high of $53.34 and a 52-week-low of $25.56. Moreover, at the end of the last trading period, the closing price was at $28.37. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
<h3>Downgrades</h3>
According to William Blair, the prior rating for Splunk Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPLK#NASDAQ">SPLK</a>) was changed from Outperform to Market Perform. Splunk earned $0.71 in the second quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Splunk shows a 52-week-high of $125.91 and a 52-week-low of $65.00. Moreover, at the end of the last trading period, the closing price was at $119.59. 
For Seelos Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEEL#NASDAQ">SEEL</a>), Guggenheim downgraded the previous rating of Buy to Neutral. In the second quarter, Seelos Therapeutics showed an EPS of $0.22, compared to $0.20 from the year-ago quarter. The current stock performance of Seelos Therapeutics shows a 52-week-high of $1.66 and a 52-week-low of $0.23. Moreover, at the end of the last trading period, the closing price was at $0.31. 
According to Argus Research, the prior rating for Silk Road Medical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILK#NASDAQ">SILK</a>) was changed from Buy to Hold. Silk Road Medical earned $0.35 in the second quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $58.04 and a 52-week-low of $15.94. At the end of the last trading period, Silk Road Medical closed at $15.98. 
Citigroup downgraded the previous rating for Frontier Group Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>) from Buy to Neutral. Frontier Group Holdings earned $0.31 in the second quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.34 and a 52-week-low of $4.78. Frontier Group Holdings closed at $4.80 at the end of the last trading period. 
For Brighthouse Financial Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHF#NASDAQ">BHF</a>), Goldman Sachs downgraded the previous rating of Neutral to Sell. Brighthouse Finl earned $4.13 in the second quarter, compared to $3.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $60.54 and a 52-week-low of $39.23. Brighthouse Finl closed at $51.27 at the end of the last trading period. 
According to Cantor Fitzgerald, the prior rating for Seelos Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEEL#NASDAQ">SEEL</a>) was changed from Overweight to Neutral. In the second quarter, Seelos Therapeutics showed an EPS of $0.22, compared to $0.20 from the year-ago quarter. The current stock performance of Seelos Therapeutics shows a 52-week-high of $1.66 and a 52-week-low of $0.23. Moreover, at the end of the last trading period, the closing price was at $0.31. 
Goldman Sachs downgraded the previous rating for BanColombia SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIB#NYSE">CIB</a>) from Buy to Neutral. For the second quarter, BanColombia had an EPS of $1.37, compared to year-ago quarter EPS of $1.78. The current stock performance of BanColombia shows a 52-week-high of $30.89 and a 52-week-low of $21.55. Moreover, at the end of the last trading period, the closing price was at $28.10. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h3>Initiations</h3>
B. Riley Securities initiated coverage on YETI Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) with a Neutral rating. The price target for YETI Holdings is set to $50.00. In the second quarter, YETI Holdings showed an EPS of $0.57, compared to $0.63 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.27 and a 52-week-low of $27.95. YETI Holdings closed at $49.55 at the end of the last trading period. 
BTIG initiated coverage on Overstock.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSTK#NASDAQ">OSTK</a>) with a Neutral rating. Overstock.com earned $0.02 in the second quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.27 and a 52-week-low of $17.05. Overstock.com closed at $17.95 at the end of the last trading period. 
With an Underperform rating, Jefferies initiated coverage on Ecopetrol SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EC#NYSE">EC</a>). The price target seems to have been set at $11.20 for Ecopetrol. Ecopetrol earned $0.45 in the second quarter, compared to $1.30 in the year-ago quarter. The current stock performance of Ecopetrol shows a 52-week-high of $13.08 and a 52-week-low of $8.59. Moreover, at the end of the last trading period, the closing price was at $12.90. 
With a Hold rating, Jefferies initiated coverage on YPF SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YPF#NYSE">YPF</a>). The price target seems to have been set at $14.50 for YPF. YPF earned $0.82 in the second quarter, compared to $2.01 in the year-ago quarter. The current stock performance of YPF shows a 52-week-high of $16.19 and a 52-week-low of $6.01. Moreover, at the end of the last trading period, the closing price was at $12.79. 
Jefferies initiated coverage on Pampa Energia SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAM#NYSE">PAM</a>) with a Buy rating. The price target for Pampa Energia is set to $56.00. For the second quarter, Pampa Energia had an EPS of $3.01, compared to year-ago quarter EPS of $1.20. The stock has a 52-week-high of $48.79 and a 52-week-low of $22.05. At the end of the last trading period, Pampa Energia closed at $40.33. 
With a Buy rating, Jefferies initiated coverage on GeoPark Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPRK#NYSE">GPRK</a>). The price target seems to have been set at $14.50 for GeoPark. GeoPark earned $0.59 in the second quarter, compared to $1.13 in the year-ago quarter. The current stock performance of GeoPark shows a 52-week-high of $16.17 and a 52-week-low of $8.83. Moreover, at the end of the last trading period, the closing price was at $10.11. 
Jefferies initiated coverage on Petroleo Brasileiro SA Petrobras (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBR#NYSE">PBR</a>) with a Buy rating. The price target for Petrobras Brasileiro is set to $21.20. Petrobras Brasileiro earned $0.90 in the second quarter, compared to $1.68 in the year-ago quarter. The current stock performance of Petrobras Brasileiro shows a 52-week-high of $16.32 and a 52-week-low of $8.88. Moreover, at the end of the last trading period, the closing price was at $15.33. 
Jefferies initiated coverage on Ultrapar Participacoes SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGP#NYSE">UGP</a>) with an Underperform rating. The price target for Ultrapar Participacoes is set to $3.30. In the second quarter, Ultrapar Participacoes showed an EPS of $0.04, compared to $0.07 from the year-ago quarter. The current stock performance of Ultrapar Participacoes shows a 52-week-high of $4.11 and a 52-week-low of $2.13. Moreover, at the end of the last trading period, the closing price was at $3.86. 
Jefferies initiated coverage on Vista Energy SAB de CV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIST#NYSE">VIST</a>) with a Buy rating. The price target for Vista Energy is set to $40.00. For the second quarter, Vista Energy had an EPS of $0.52, compared to year-ago quarter EPS of $1.06. At the moment, the stock has a 52-week-high of $28.37 and a 52-week-low of $8.37. Vista Energy closed at $27.00 at the end of the last trading period. 
Barclays initiated coverage on Organon &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGN#NYSE">OGN</a>) with an Overweight rating. The price target for Organon is set to $28.00. For the second quarter, Organon had an EPS of $1.31, compared to year-ago quarter EPS of $1.25. At the moment, the stock has a 52-week-high of $32.43 and a 52-week-low of $18.87. Organon closed at $18.92 at the end of the last trading period. 
Barclays initiated coverage on Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) with a Equal-Weight rating. The price target for Alvotech is set to $10.00. At the moment, the stock has a 52-week-high of $14.60 and a 52-week-low of $5.56. Alvotech closed at $9.10 at the end of the last trading period. 
For Broadstone Net Lease Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNL#NYSE">BNL</a>), JMP Securities initiated coverage, by setting the current rating at Market Perform. In the second quarter, Broadstone Net Lease showed an EPS of $0.35, compared to $0.35 from the year-ago quarter. The current stock performance of Broadstone Net Lease shows a 52-week-high of $18.86 and a 52-week-low of $14.99. Moreover, at the end of the last trading period, the closing price was at $15.97. 
Wells Fargo initiated coverage on Realty Income Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) with a Equal-Weight rating. The price target for Realty Income is set to $59.00. For the second quarter, Realty Income had an EPS of $1.00, compared to year-ago quarter EPS of $0.97. The current stock performance of Realty Income shows a 52-week-high of $68.85 and a 52-week-low of $53.65. Moreover, at the end of the last trading period, the closing price was at $53.80. 
Wells Fargo initiated coverage on Agree Realty Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) with an Overweight rating. The price target for Agree Realty is set to $70.00. For the second quarter, Agree Realty had an EPS of $0.98, compared to year-ago quarter EPS of $0.97. The current stock performance of Agree Realty shows a 52-week-high of $75.71 and a 52-week-low of $58.65. Moreover, at the end of the last trading period, the closing price was at $58.72. 
Wells Fargo initiated coverage on Four Corners Property Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCPT#NYSE">FCPT</a>) with an Overweight rating. The price target for Four Corners Prop is set to $28.00. For the second quarter, Four Corners Prop had an EPS of $0.42, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $29.30 and a 52-week-low of $22.70. At the end of the last trading period, Four Corners Prop closed at $24.13. 
With an Overweight rating, Wells Fargo initiated coverage on Essential Properties Realty Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPRT#NYSE">EPRT</a>). The price target seems to have been set at $27.00 for Essential Props Realty. Essential Props Realty earned $0.41 in the second quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $26.43 and a 52-week-low of $18.89. At the end of the last trading period, Essential Props Realty closed at $23.48. 
Wells Fargo initiated coverage on VICI Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICI#NYSE">VICI</a>) with an Overweight rating. The price target for VICI Props is set to $36.00. In the second quarter, VICI Props showed an EPS of $0.54, compared to $0.48 from the year-ago quarter. The current stock performance of VICI Props shows a 52-week-high of $35.07 and a 52-week-low of $28.49. Moreover, at the end of the last trading period, the closing price was at $30.66. 
With an Underweight rating, Wells Fargo initiated coverage on Spirit Realty Capital Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRC#NYSE">SRC</a>). The price target seems to have been set at $36.00 for Spirit Realty Cap. In the second quarter, Spirit Realty Cap showed an EPS of $0.91, compared to $0.90 from the year-ago quarter. The stock has a 52-week-high of $44.65 and a 52-week-low of $34.44. At the end of the last trading period, Spirit Realty Cap closed at $36.67. 
Wells Fargo initiated coverage on EPR Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPR#NYSE">EPR</a>) with an Underweight rating. The price target for EPR Props is set to $40.00. For the second quarter, EPR Props had an EPS of $1.28, compared to year-ago quarter EPS of $1.17. At the moment, the stock has a 52-week-high of $47.71 and a 52-week-low of $33.92. EPR Props closed at $42.76 at the end of the last trading period. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

ALVO

Brighthouse Financial, Inc. - Common Stock

EPRT

EWCZ

FCPT

FIVN

GPRK

NTNX

OSTK

SEEL

SILK

SPLK

ULCC

VICI

VIST

YETI

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023

Bancolombia S.A. declares $0.8456 dividend

Warning: CIB is at high risk of cutting its dividend

Bancolombia (CIB) has released an update. Bancolombia S.A. has announced leadership appointments within its board, reelecting Luis Fernando Restrep...

Bancolombia Announces Board Appointments and New Committee

JPMorgan in charts: Asset & Wealth Management revenue maintains upward momentum in Q3

Bancolombia (CIB) has released an update. Bancolombia S.A. has announced the redemption of its 3.000% Senior Notes due 2025 and 4.625% Subordinated...

Bancolombia Announces Redemption of Senior and Subordinated Notes

Bancolombia (CIB) has released an update. Bancolombia S.A. plans to restructure its corporate framework by establishing a new holding company, Grup...

Bancolombia Restructures with New Holding Company

Press Releases

BANCOLOMBIA S.A. ANNOUNCES FILING OF THE 2023 ANNUAL REPORT ON FORM 20-F

Bancolombia S.A. Accepts to Purchase All Tendered and Not Validly Withdrawn Offers of Bancolombia S.A.'s Outstanding 3.000% Senior Notes Due 2025 and 6.909% Subordinated Notes Due 2027

Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)

Grupo Aval Acciones

Credicorp

Banco BBVA Argentina

Banco Bradesco Sa American Depositary Shares

Bank Bradesco

Banco Bradesco Sa American Depositary Shares (each representing one Common Share)

Banco De Chile

Banco Macro S.A. ADR (representing Ten Class B Common Shares)

Banco Macro

Banco Santander Chile

Comerica

First Citizens BancShares, Inc. - Class A Common Stock

First Citizens BancShares

Fifth Third Bancorp

Grupo Financiero Galicia S.A. - American Depositary Shares, Class B Shares underlying

Grupo Financiero Galicia

Intercorp Financial Services Inc. Common Shares

Intercorp Financial Servs

Inter & Co

KB Financial Group

KeyCorp

Shinhan Financial Group Co Ltd American Depositary Shares

Shinhan Finl Gr

Grupo Supervielle S.A. American Depositary Shares each Representing five Class B shares

Grupo Supervielle

Woori Financial Group Inc. American Depositary Shares (each representing three (3) shares of Common Stock)

Comments

BanColombia

Noticias

Últimas noticias sobre BanColombia (NYSE:CIB) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL